Serum IL-8 level as a candidate prognostic marker of response to anti-angiogenic therapy for metastatic colorectal cancer.

Mitsukuni SuenagaTetsuo MashimaNaomi KawataTakeru WakatsukiShingo DanHiroyuki SeimiyaKensei Yamaguchi

Published in: International journal of colorectal disease (2020)

Circulating IL-8 and Ang-2 levels are associated with LM in mCRC patients. IL-8 may be a prognostic marker of response to anti-angiogenic therapy, regardless of the treatment timing.

Keyphrases

metastatic colorectal cancer
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
stem cells
mesenchymal stem cells
patient reported outcomes
bone marrow
replacement therapy